Evelo Biosciences, Inc.
EVLO
$0.0003
-$0.0002-40.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 126.48% | -72.26% | -42.70% | -30.58% | -24.95% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -54.02% | 39.56% | -28.19% | 10.97% | -29.44% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 68.13% | -62.56% | -41.67% | -28.69% | -25.44% |
|
|
|||||
| Total Current Assets | 68.13% | -62.56% | -41.67% | -28.69% | -25.44% |
| Net Property, Plant & Equipment | -89.01% | -24.22% | -8.34% | -8.89% | -6.43% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -43.95% | 23.01% | -0.17% | 0.17% | 0.09% |
| Total Assets | -0.92% | -50.40% | -34.87% | -25.36% | -22.85% |
|
|
|||||
| Total Accounts Payable | -86.03% | 148.68% | -14.17% | 13.81% | -31.05% |
| Total Accrued Expenses | -11.67% | -45.81% | 19.65% | -36.33% | 19.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -27.16% | 1.06% | 1,941.48% | -81.59% | 52.77% |
| Total Finance Division Other Current Liabilities | 3,585.00% | -81.82% | -74.24% | -30.79% | -16.30% |
| Total Other Current Liabilities | 3,585.00% | -81.82% | -74.24% | -30.79% | -16.30% |
| Total Current Liabilities | -28.41% | -2.98% | 361.86% | -53.95% | 25.54% |
|
|
|||||
| Total Current Liabilities | -28.41% | -2.98% | 361.86% | -53.95% | 25.54% |
| Long-Term Debt | -- | -- | -- | 19.00% | -10.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -15.35% | -13.03% | -11.29% | -9.61% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.60% | -0.05% | -7.68% | 8.79% | 0.00% |
| Total Liabilities | -29.29% | -3.48% | -0.11% | -9.83% | 0.98% |
|
|
|||||
| Common Stock & APIC | 6.00% | 0.45% | 0.56% | 1.79% | 0.83% |
| Retained Earnings | -2.15% | -3.81% | -4.79% | -4.66% | -6.43% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 42.10% | -68.42% | -448.64% | -153.48% | -73.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 42.10% | -68.42% | -448.64% | -153.48% | -73.82% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 42.10% | -68.42% | -448.64% | -153.48% | -73.82% |
|
|
|||||